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Abstract Because of the classification of the nickel
compounds as carcinogenic substances, there is a need for
in vivo tests to nickel nanoparticles (NiNPs) for observing
their effects on health experimentally. Spherical NiNPs
with 10 nm in diameter and 75 ppm concentration were
applied for investigating their toxicities within male albino
mice as an in vivo model. We randomly made sham group,
control group, and 75 ppm group (with five animals in each
group). Then, the nanoparticles were injected into mice
intraperitonealy for 7 days and after that their lungs, liver,
and spleen were removed for histopathological observa-
tions. At the end of the test, section microscopic observa-
tions of liver, spleen, and lung in sham and control groups
showed normal tissues but these tissues underwent signif-
icant abnormal effects in 75 ppm group. NiNPs can cause
undesirable effects in lungs, liver, and spleen tissues with
same condition of this study.
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Introduction
The production of highly functional materials by utilizing
diverse properties of nanoparticles has already begun;
however, the effects of them on humans have not been
elucidated [1]. Absorbed nanoparticles by binding to pro-
teins of plasma can enter the cells and penetrate into organs
such as lung, stomach, brain, liver, kidney, heart, and tes-
ticles [2]. If these particles are toxic, defense mechanisms
by reactive oxygen species (ROS) generation will result in
injuries to tissues [3–5].
Liver is the first target for absorbed materials from
gastrointestinal tract before becoming systemic [6]. Inter-
ference with the antioxidants takes place in the liver and
spleen. Spleen as an organ that is part of the immune
system can be a storage site for lymphocytes for immunity
and defense against infection and filtering the blood.
The lungs because of their high blood supply and their
ability to concentrate toxins are mainly susceptible to
xenobiotics.
Still recent studies were not well suited to demonstrating
effects of nickel nanoparticles on tissues that surely depend
on exposure way, duration of treatment, dose, and nano-
particle features. So in this study, we attempted to inves-
tigate toxic effects of spherical nickel nanoparticles with




NiNPs colloid solution with diameter of 10 nm and con-
centration of 100 ppm was purchased from Notrino.Co of
Tehran and then size and shape of them were controlled by
transmission electron microscopy (TEM). After that,
required dose was prepared (75 ppm) by diluting with
distilled water.
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Experimental animals and their treatment
Fifteen male albino strain mice with 8 week old and 24 g
average weight were purchased from Isfahan University and
were randomly group housed (sham group, control group,
75 ppm group) in standard caging with sawdust bedding,
environmental enrichment with free access to sterile water
and food in pathogen-free and standard condition with
National Institutes of Health guidelines for the human use of
laboratory animals. The animals were maintained on a
normal 12 h light and dark cycle, at a temperature of
25–27 C, relative humidity of 10 ± 60 % and were
allowed 7 days to acclimatize prior to study commence-
ment. 5 animals in sham group were fed just with normal
food and water without any injection, 5 mice in control
group were injected with 0.3 ml/day distilled water intra-
peritonealy, and 5 mice in 75 ppm group were injected with
0.3 ml/day NiNPs intraperitonealy for 1 week.
Sample collection
Following the last treatment, all animals were anesthetized by
intraperitoneal injection of ketamine and for histological
examinations, after cutting abdomen and removing lungs, liver,
and spleen tissues from each mouse, fresh portions of the lateral
lobes of them were cut rapidly into 2 lm-thick sections. They
were fixed in neutral buffered formalin (10 %), and then
dehydrated with grades of ethanol (70, 80, 90, 95 and 100 %).
Dehydration was then followed by clearing the samples in two
changes of xylene. Samples were then impregnated with two
changes of molten paraffin wax, then embedded and blocked
out. Paraffin sections were stained with hematoxylin and eosin
(H&E). They were monitored under light microscope and the
photomicrographs of them were obtained.
Statistical analysis
All data were stored in SPSS (version 19). Group com-
parisons were done using the Student’s t test (for com-
paring weights) and analysis of variance (ANOVA) test
with Dunnett post-test (for comparing tissues of treated
groups vs. control group). All data were expressed as
mean ± standard error of mean (SEM). P values less than
0.05 were considered to be significant.
Results
Control of NiNps
The morphology and size of the purchased NiNPs were con-
trolled using transmission electron microscopy CM10 Philips
(TEM). The images clearly show that the average size of the
particles was found to be in the order of 10 nm and they were
relatively uniform in diameter with spherical shape (Fig. 1).
TEM consisted of a long column with source of electron rays
on top that after transmitting through the specimen, electron
rays hit a photographic film or screen, built of fluorescent
materials, and create an image. Since some rays do not pass
through the sample, black spots are left on the image and
therefore electron microscope images are black and white.
Animals’ body weight and appearance
The body weight alterations of male mice before and after the
treatment of NiNPs show non-significant differences (p[0.05).
Appearance of animals during the treatment was normal. Fur-
thermore, no mortality was observed during the test.
Liver tissue
The image of liver tissue sections of mice in sham and
control group including hepatocytes, nuclei, hepatic cords,
hexagon lobules, sinusoids, central veins, and portal veins
were normal. But microscopic images of liver in 75 ppm
group in comparison with sham group showed significant
changes like hyperemia and expansions of central veins.
Also, secretions of inflammatory cells including neutro-
phils and lymphocytes and increasing bile ductules were
shown in portal veins. Heptocytes were hyperchromia rel-
atively. Kupffer cells were swelled. Also dispersed apop-
tosis was seen (Fig. 2; Table 1).
Spleen tissue
Structure of spleen tissue in sham and control groups was
natural but microscopic images of 75 ppm group versus
Fig. 1 Image of NiNPs by TEM
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these groups showed some significant differences including
sharp augmentation of number of macrophages and intense
congestion of red pulp. Also in this group, sinusoids had
been widened (Fig. 2; Table 1).
Lung tissue
Lung tissue sections in the sham and control groups
showed normal bronchiolar epithelium and goblet cells but
histological alterations in the group that daily were
receiving 0.3 ml of NiNPs intraperitonealy for one week in
comparison with previous groups showed significant dif-
ferences; for example some alveoli had became small and
increase of interstitial fibrosis together with plenty
excretion of lymphocytic exudates among intra alveoli area
was showed. By the way any sign of peribronchiolite or
perivasculitis was not seen (Fig. 2; Table 1).
Discussion
In many researches skin penetration of nickel particles
resulting in nickel allergy or inhalation of nickel particles
there by producing lung injury or inflammation have been
reported [7–11] and now in this study, we tried to inves-
tigate effects of intraperitoneal injection of NiNPs on three
key tissues. Most studies confirmed that administrated
nanoparticles are primarily taken up by liver and spleen in
a large quantity and by lung, kidney, heart, and brain in
small amounts after single administration [12]. Further-
more, some nanoparticles by producing reactive oxygen
species and inducing oxidative stress cause organ injuries
[13, 14], so careful assessment of undesired effects of them
in the body is important. Obtained results of histopatologic
investigations in present study also emphasized those
results of researches and showed low to high abnormalities
in liver, spleen, and lung tissues in treated mice by NiNPs
because liver and spleen act as filters for blood and by
metabolizing of xenobiotics with several reactions and
their vulnerabilities cause fewer damages to the body.
In the present study, lung tissue was also affected by
NiNPs even though they were administrated intraperito-
nealy and this shows NiNPs through circulation have
reached to lung organ and caused adverse biological
Fig. 2 Histopathology effects
of NiNPs on liver (a sham
group, b control group,
c 75 ppm group), spleen
(d sham group, e control group,
f 75 ppm group), and lung
(g sham group, h control group,
i 75 ppm group) in mice by
injecting method, H & E
staining, magnification 4009
Table 1 Comparing injury grades of tissues in treated groups vs.
tissues of sham group
Groups Number Degregation Mean ± SEM p value
Sham 5 Liver 0.0 ± 0.0 1.000
Spleen 0.0 ± 0.0 1.000
Lung 0.0 ± 0.0 1.000
Control 5 Liver 0.0 ± 0.0 1.000
Spleen 0.0 ± 0.0 1.000
Lung 0.0 ± 0.0 1.000
75 ppm 5 Liver 1.6 ± 0.5 0.004**
Spleen 1.0 ± 0.4 0.033*
Lung 0.8 ± 0.4 0.041*
* and ** indicate significant difference p \ 0.01 and p \ 0.001,
respectively, vs. sham group
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reactions. Some other data have confirmed a correlation
between airborne nanoparticles derived from the combus-
tion of fossil fuel like nickel particles and cardiovascular
diseases [15]. Nickel oxide is a nickel compound with
extremely poor solubility that is considered to have high
biopersistence in the lung [16]. Poland et al. [17] also
studied intraperitoneal injection and aspiration effects of
nickel nanowire with diameter of 200 nm and length of
more than 20 lm in mice and found out that they caused
strong inflammation in mouse peritoneal cavity and lung,
respectively, in a dose-dependent manner, so they con-
firmed their hazard potential. Also, the study results of
Magaye et al. [18] 14 days after intravenous injection of
2 ml of Ni nanoparticles (with diameter of 50 nm and three
doses 1, 10 and 20 mg/kg) in rats indicate acute toxicity of
NiNPs because they induced liver and spleen injury, lung
inflammation, and cardiac toxicity.
Conclusion
Administrating NiNPs with the same condition of this
study could cause disorder on liver, spleen and lung tissues
of mice; so they can have hazard potential for human
health. Of course these results need more research and
application of a gradient of NiNPs doses to find toxic and
safe doses for using Ni nanoparticles or Ni compounds, for
example, in nanomedicine is necessary.
Open Access This article is distributed under the terms of the
Creative Commons Attribution License which permits any use, dis-
tribution, and reproduction in any medium, provided the original
author(s) and the source are credited.
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